LONDON, May 17, 2017 /PRNewswire/ -- There has been an exponential rise in the occurrence of various diseases. Enzyme inhibitors are used as diagnostic agents to detect various diseases thus fueling the growth of enzyme inhibitor market. Moreover, usage of these inhibitors in the manufacturing of pesticides and herbicides favours the market growth. However, the existence of strict regulations increases the cost as well as launch period of new drugs, thereby hampering the growth of the global market. Download the full report: https://www.reportbuyer.com/product/4823104/Developing nations of North America and Europe has high growth because of improved diagnosis rate for the diseases, accessibility of medical facility and presence of established infrastructure. Asia Pacific market is expected to flourish due to the existence of large patient pool, enhancing healthcare infrastructure in developing nations such as India, China, and South Korea. Some of the key players in the market include Amgen, AstraZeneca, Bayer AG, Eli Lilly, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer, Ranbaxy Laboratories Ltd, Roche and Takeda Pharma. Type of Enzyme Inhibitors Covered:
- Reversible - Irreversible End Users Covered:
- Agrochemical - Pharmaceutical - Biotechnology - Food & Beverage - Other End Users Disease Indications Covered:
- Arthritis - Cardiovascular Disease - Chronic Obstructive Pulmonary Disorders - Gastrointestinal Disorders - Inflammatory Diseases - Other Diseases Applications Covered:
- Pesticide Synthesis - Drug Development - Diagnostic Agent - Other Applications Regions Covered:
- North America
o US o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
What our report offers:
- Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements Download the full report: https://www.reportbuyer.com/product/4823104/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com
For more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/enzyme-inhibitor---global-market-outlook-2016-2022-300459499.html
SOURCE ReportBuyer
